夏科-莱登结晶蛋白/半乳糖凝集素-10 是哮喘中嗜酸性气道炎症的替代生物标志物。
Charcot-Leyden crystal protein/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma.
机构信息
Department of Medicine, University of Illinois at Chicago, IL 60612, USA.
Department of Biochemistry & Molecular Genetics, University of Illinois at Chicago, IL 60612, USA.
出版信息
Biomark Med. 2019 Jun;13(9):715-724. doi: 10.2217/bmm-2018-0280. Epub 2019 Jun 3.
Abstract
Eosinophilic asthma is associated with more exacerbations and differential responses to treatment. The aim of this study was to assess if CLC/Gal-10 and MBP-1 are surrogate biomarkers of eosinophilic inflammation in asthma. Sputum induction was performed in patients with asthma and in healthy controls. Sputum analysis revealed higher (p < 0.001) levels of CLC/Gal-10 and MBP-1 in asthmatics versus healthy controls. CLC/Gal-10 levels were highly correlated (r = 0.74; p < 0.001) with sputum eosinophils; MBP-1 approached significance (r = 0.44; p = 0.07). Increased CLC/Gal-10 and MBP-1 levels in the sputum were strongly correlated with sputum eosinophils in patients with asthma. CLC/Gal-10 and MBP-1 may be useful biomarkers for differentiation of eosinophilic airway inflammation in asthma.
摘要
嗜酸性粒细胞性哮喘与更多的恶化和治疗反应差异有关。本研究旨在评估 CLC/Gal-10 和 MBP-1 是否是哮喘中嗜酸性炎症的替代生物标志物。对哮喘患者和健康对照者进行了痰诱导。痰分析显示，哮喘患者的 CLC/Gal-10 和 MBP-1 水平明显高于健康对照组（p < 0.001）。CLC/Gal-10 水平与痰中嗜酸性粒细胞高度相关（r = 0.74；p < 0.001）；MBP-1 接近显著相关（r = 0.44；p = 0.07）。哮喘患者痰中 CLC/Gal-10 和 MBP-1 水平的增加与痰中嗜酸性粒细胞强烈相关。CLC/Gal-10 和 MBP-1 可能是区分哮喘嗜酸性气道炎症的有用生物标志物。
相似文献
1
Charcot-Leyden crystal protein/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma.
Biomark Med. 2019 Jun;13(9):715-724. doi: 10.2217/bmm-2018-0280. Epub 2019 Jun 3.
2
Galectin-10, a potential biomarker of eosinophilic airway inflammation.
PLoS One. 2012;7(8):e42549. doi: 10.1371/journal.pone.0042549. Epub 2012 Aug 6.
3
Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis.
J Allergy Clin Immunol. 2020 Aug;146(2):377-389.e10. doi: 10.1016/j.jaci.2020.01.013. Epub 2020 Jan 23.
4
Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases.
Am Rev Respir Dis. 1984 Dec;130(6):1072-7. doi: 10.1164/arrd.1984.130.6.1072.
5
Charcot-Leyden Crystal Protein in Nasal Secretions of Patients with Nonallergic Rhinitis with Eosinophilia Syndrome.
Int Arch Allergy Immunol. 2020;181(11):888-896. doi: 10.1159/000509252. Epub 2020 Jul 21.
6
Increased epithelial galectin-13 expression associates with eosinophilic airway inflammation in asthma.
Clin Exp Allergy. 2021 Dec;51(12):1566-1576. doi: 10.1111/cea.13961. Epub 2021 Jun 19.
7
Galectin-10, the protein that forms Charcot-Leyden crystals, is not stored in granules but resides in the peripheral cytoplasm of human eosinophils.
J Leukoc Biol. 2020 Jul;108(1):139-149. doi: 10.1002/JLB.3AB0220-311R. Epub 2020 Feb 28.
8
Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.
Respir Med. 2015 Nov;109(11):1391-6. doi: 10.1016/j.rmed.2015.09.016. Epub 2015 Oct 9.
9
Charcot-Leyden Crystals in Eosinophilic Inflammation: Active Cytolysis Leads to Crystal Formation.
Curr Allergy Asthma Rep. 2019 Jun 15;19(8):35. doi: 10.1007/s11882-019-0868-0.
10
Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
J Allergy Clin Immunol. 2010 Jul;126(1):61-9.e3. doi: 10.1016/j.jaci.2010.03.026.
引用本文的文献
1
C-BIOPRED severe asthma clinical phenotypes: link to complement and coagulation pathways and galectin 10.
ERJ Open Res. 2025 Aug 11;11(4). doi: 10.1183/23120541.01016-2024. eCollection 2025 Jul.
2
Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and disease.
Nat Rev Immunol. 2024 Dec;24(12):858-877. doi: 10.1038/s41577-024-01048-y. Epub 2024 Jul 9.
3
The Role of Galectins in Asthma Pathophysiology: A Comprehensive Review.
Curr Issues Mol Biol. 2024 May 3;46(5):4271-4285. doi: 10.3390/cimb46050260.
4
Mucus plugs in the airways of asthmatic subjects and smoking status.
Respir Res. 2024 Jan 23;25(1):52. doi: 10.1186/s12931-024-02665-w.
5
Development and Validation of Serum Markers as Noninvasive Diagnostic Methods for Achalasia.
Clin Transl Gastroenterol. 2024 Jan 1;15(1):e00651. doi: 10.14309/ctg.0000000000000651.
6
Lactose and Galactose Promote the Crystallization of Human Galectin-10.
Molecules. 2023 Feb 19;28(4):1979. doi: 10.3390/molecules28041979.
7
Transcriptome-wide association study of circulating IgE levels identifies novel targets for asthma and allergic diseases.
Front Immunol. 2023 Jan 30;14:1080071. doi: 10.3389/fimmu.2023.1080071. eCollection 2023.
8
Galectin-10 as a Potential Biomarker for Eosinophilic Diseases.
Biomolecules. 2022 Sep 27;12(10):1385. doi: 10.3390/biom12101385.
9
Pulmonary Eosinophils at the Center of the Allergic Space-Time Continuum.
Front Immunol. 2021 Nov 15;12:772004. doi: 10.3389/fimmu.2021.772004. eCollection 2021.
10
The Transcriptome Characteristics of Severe Asthma From the Prospect of Co-Expressed Gene Modules.
Front Genet. 2021 Oct 25;12:765400. doi: 10.3389/fgene.2021.765400. eCollection 2021.
本文引用的文献
1
A sputum gene expression signature predicts oral corticosteroid response in asthma.
Eur Respir J. 2017 Jun 29;49(6). doi: 10.1183/13993003.00180-2017. Print 2017 Jun.
2
Race is associated with differences in airway inflammation in patients with asthma.
J Allergy Clin Immunol. 2017 Jul;140(1):257-265.e11. doi: 10.1016/j.jaci.2016.10.024. Epub 2017 Jan 6.
3
Biomarkers in asthmatic patients: Has their time come to direct treatment?
J Allergy Clin Immunol. 2016 May;137(5):1317-24. doi: 10.1016/j.jaci.2016.03.009.
4
Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
J Allergy Clin Immunol. 2015 Feb;135(2):299-310; quiz 311. doi: 10.1016/j.jaci.2014.12.1871.
5
Eosinophil granule proteins: form and function.
J Biol Chem. 2014 Jun 20;289(25):17406-15. doi: 10.1074/jbc.R113.546218. Epub 2014 May 6.
6
Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes.
J Allergy Clin Immunol. 2014 Apr;133(4):997-1007. doi: 10.1016/j.jaci.2013.12.1091. Epub 2014 Feb 28.
7
Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia.
Allergy. 2013 Sep;68(9):1177-84. doi: 10.1111/all.12206. Epub 2013 Aug 9.
8
Phenotypes and endotypes of uncontrolled severe asthma: new treatments.
J Investig Allergol Clin Immunol. 2013;23(2):76-88; quiz 1 p. follow 88.
9
Asthma phenotypes and endotypes: an evolving paradigm for classification.
Discov Med. 2013 Apr;15(83):243-9.
10
The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis.
Gut. 2013 Oct;62(10):1395-405. doi: 10.1136/gutjnl-2012-303171. Epub 2012 Aug 15.
Zotero 插件